Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Damsin

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Dermatology and Therapy|June 2, 2023
A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with TildrakizumabThomas Damsin
Revue Medicale De Liege|June 16, 2025
[Vaccination recommendations for psoriasis patients treated with biologics]Thomas Damsin, Gilles Absil, Florence Libon, et al.
Revue Medicale De Liege|June 8, 2026
[Climate change and skin]Thibaut Delahaye, Gilles Absil, Thomas Damsin, et al.
Psoriasis (Auckland, N.Z.)|January 9, 2025
Breakthrough Psoriasis in Patients Receiving BiologicalsThomas Damsin, Gilles Absil, Florence Libon, et al.
Expert Review of Anticancer Therapy|February 17, 2022
Cemiplimab for locally advanced and metastatic basal cell carcinomaThomas Damsin, Eve Lebas, Nathalie Marchal, et al.
Dermatology and Therapy|September 18, 2020
Value of Teledermoscopy in Primary Healthcare Centers: Preliminary Results of the TELESPOT Project in BelgiumThomas Damsin, Gregory Canivet, Pauline Jacquemin, et al.
European Journal of Dermatology : EJD|October 13, 2021
The impact of COVID-19 on the new diagnoses of melanomaChristophe Gedeah, Thomas Damsin, Gilles Absil, et al.
Clinical Drug Investigation|April 3, 2023
Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective StudyAxel De Greef, Pierre-Dominique Ghislain, Audrey Bulinckx, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Dermatology and Therapy|June 2, 2023
A Case of Concurrent Psoriasis and Hidradenitis Suppurativa Successfully Treated with TildrakizumabThomas Damsin
Revue Medicale De Liege|June 16, 2025
[Vaccination recommendations for psoriasis patients treated with biologics]Thomas Damsin, Gilles Absil, Florence Libon, et al.
Revue Medicale De Liege|June 8, 2026
[Climate change and skin]Thibaut Delahaye, Gilles Absil, Thomas Damsin, et al.
Psoriasis (Auckland, N.Z.)|January 9, 2025
Breakthrough Psoriasis in Patients Receiving BiologicalsThomas Damsin, Gilles Absil, Florence Libon, et al.
Expert Review of Anticancer Therapy|February 17, 2022
Cemiplimab for locally advanced and metastatic basal cell carcinomaThomas Damsin, Eve Lebas, Nathalie Marchal, et al.
Dermatology and Therapy|September 18, 2020
Value of Teledermoscopy in Primary Healthcare Centers: Preliminary Results of the TELESPOT Project in BelgiumThomas Damsin, Gregory Canivet, Pauline Jacquemin, et al.
European Journal of Dermatology : EJD|October 13, 2021
The impact of COVID-19 on the new diagnoses of melanomaChristophe Gedeah, Thomas Damsin, Gilles Absil, et al.
Clinical Drug Investigation|April 3, 2023
Real-Life Experience of Tralokinumab for the Treatment of Adult Patients with Severe Atopic Dermatitis: A Multicentric Prospective StudyAxel De Greef, Pierre-Dominique Ghislain, Audrey Bulinckx, et al.
Pageof 1